Charles Explorer logo
🇬🇧

OS - Clinical Pharmacology

Class at Second Faculty of Medicine |
DVA1028

Syllabus

Syllabus - Clinical Pharmacology

The Optional Subject is mainly recommended to 5th year and above students of Medicine

Organized by: Department of Medical Chemistry and Clinical Biochemistry,

Division of Clinical Pharmacology.

All interested may contact: MUDr. Hundie Tesfaye, Ph.D. on ext. Tel. 5656, Motol Hospital

Capacity: max. 10 students/group

The Optional Subject is scheduled to take place from 25. 3. - 29. 3. 2024 usually starting at 14:00 and lasting 3-4 hours for five consecutive working days.

Location: 2nd Floor, G (Pediatric part of the hospital building).

During the study of preclinical compulsory courses, the medical student is hardly engaged in patient management or confronted with the real clinical problem. Pharmacology is one of the basic subjects included in mandatory preclinical subjects, where the student mainly works hard to overcome anatomy of drugs and classes.

Therefore, the course offered now is aiming to help the shortly graduating future physicians how to practice rational pharmacotherapy. The course is limited to few students to work in small group after consecutive lectures. After attending the course supported by interactive discussion and case problem solving, the student is expected to have better knowledge of modern aspects of pharmacokinetics and its clinical importance, challenges associated to clinical trials and good clinical practice, problem of generics versus patented drugs, drugs prescription in special populations, importance of therapeutic drug monitoring and rational pharmacotherapy.

The overall scope of the course is to emphasize the need of individual approach to help achieving quality care for patients complying with the evidence-based medicine.

* Day 1. (25.3.2024) Core lectures 1/ Introduction to Clinical Pharmacology 2/ Good Clinical practice 3/ Phases of Clinical trials in human subjects I-IV and ethical challenges 4/ Pharmaceutical aspects of drugs and clinical importance 5/ Adverse drug reactions, role of pharmacovigilance

* Day 2. (26.3.2024) Lecture + Work-shop

Standard operation procedures during drug prescription/good prescribing practice.

* Day 3. (27.3.2024) Lecture + Work-shop

Special population PK/PD and clinical importance

* Day 4. (28.3.2024) Lecture + Work-shop

Drug-drug interaction risk, PK/PD and toxicological significances

* Day 5. (29.3.2024) Lecture + Work-shop

Importance and methods of therapeutic drug concentration monitoring in biological specimen

Lectures on days 2-5 will be followed by workshops aiming at interactive discussion and case-supported learning.

Terms and conditions to get course attendance credits:

Attendance of minimum 4 out of 5 days or 3 out of 5 days provided that an attendee must perform pharmacological analysis of 4 model clinical cases including appropriate resolution and recommendations.

N.B.: International students, who attended the course as complementary to Erasmus programme, must take examination composed of triple of questions only in case they request classified grading marks.

This text is not available in the current language. Showing version "cs".Annotation

The Optional Subject is mainly recommended to 5th year and above students of Medicine

Organized by: Department of Medical Chemistry and Clinical Biochemistry,

Division of Clinical Pharmacology.

All interested may contact: MUDr. Hundie Tesfaye, Ph.D. on ext. Tel. 5656, Motol Hospital

Capacity: max. 10 students/group

The Optional Subject is scheduled to take place from 25. 3. - 29. 3. 2024 usually starting at 14:00 and lasting 3-4 hours for five consecutive working days.

Location: 2nd Floor, G (Pediatric part of the hospital building).